Inhibitors of arginase and their therapeutic applications
US9266908B2 · kind B2 · utility
17Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 2012 |
| Grant date | Feb 23, 2016 |
| Priority date | — |
| Expiry date | Oct 18, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The inventive compounds are small molecule therapeutics that are potent inhibitors of Arginase I and II activity. The invention also provides pharmaceutical compositions of the inventive compounds and methods for using the inventive compounds for treating or preventing a disease or a condition associated with arginase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.